Globavend is trading at $1.09, up 19.76%, with no identified catalyst.

  • No company-specific announcement dated October 29 was identified; the latest reported company news predates the move.
  • The October 27 Shenzhen subsidiary announcement also predates the session and does not establish a cause.
  • Software-sector weakness and broad-market declines ran counter to Globavend’s rise; thin liquidity is context, not a confirmed catalyst.